{"nctId":"NCT01370538","briefTitle":"Efficacy of Esomeprazole in Patients With Frequent Heartburn","startDateStruct":{"date":"2011-08"},"conditions":["Heartburn"],"count":341,"armGroups":[{"label":"Esomeprazole 20 mg","type":"EXPERIMENTAL","interventionNames":["Drug: Esomeprazole"]},{"label":"Placebo","type":"PLACEBO_COMPARATOR","interventionNames":["Drug: Esomeprazole"]}],"interventions":[{"name":"Esomeprazole","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Males and non-pregnant ,non-lactating females 18 years or older\n* Experience heartburn at least 2 days a week\n* Having heartburn that has responded to heartburn medication\n* Must discontinue any current heartburn medications\n\nExclusion Criteria:\n\n* Having a history of erosive esophagitis verified by endoscopy\n* Having a history of GERD which was diagnosed by a physician\n* Inability to take study medication or complete the study and all study procedures\n* Subjects that have required more than one 14-day course of PPI treatment within the past 4 months","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":true},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Percentage of Heartburn Free 24 Hour Days During 14 Days of Randomized Treatment","description":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"46.79","spread":"33.32"},{"groupId":"OG001","value":"30.93","spread":"28.86"}]}]}]},{"type":"SECONDARY","title":"Number of Subjects Reporting Heartburn 2 Days or Less During the 14 Days Randomized Treatment Period","description":"Treatment period is considered to be both weeks 1 and 2 between V3 and V4.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"27","spread":null},{"groupId":"OG001","value":"2","spread":null}]}]}]},{"type":"SECONDARY","title":"Comparison of Number of Subjects With 0, 1, 2, 3 or 4 Days With no Heartburn Over Days 1 to 4 Between Esomeprazole 20 mg and Placebo","description":"The first 4 consecutive days subjects were on randomized treatment, between V3 and V4.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"55","spread":null},{"groupId":"OG001","value":"77","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"32","spread":null},{"groupId":"OG001","value":"34","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"22","spread":null},{"groupId":"OG001","value":"29","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"37","spread":null},{"groupId":"OG001","value":"16","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"16","spread":null},{"groupId":"OG001","value":"2","spread":null}]}]}]},{"type":"SECONDARY","title":"Number of Subjects With Heartburn 1 Day or Less During the Final Week, Second Week, First Week of Treatment","description":"There were three separate 7 day time periods during the treatment period; The first week (days 1-7), the second week (days 8-14), and the last 7 consecutive days (last day subject reported and the prior 6). For a given subject, the second week and last 7 consecutive days are the same if the subject has recorded measurements for the entire 14 day treatment period. However, for subjects reporting anything less than 14 days the two will not be identical. For all three 7 day time periods, days when a subject did not call in (i.e., missing values) were imputed as a day with heartburn.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"40","spread":null},{"groupId":"OG001","value":"17","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"38","spread":null},{"groupId":"OG001","value":"13","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"32","spread":null},{"groupId":"OG001","value":"7","spread":null}]}]}]},{"type":"PRIMARY","title":"Percentage of Heartburn Free 24 Hour Days During 14 Days of Randomized Treatment","description":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"47.82","spread":"33.23"},{"groupId":"OG001","value":"28.83","spread":"31.22"}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0,"n":162},"commonTop":["Nausea","Diarrhoea","Constipation","Nasopharyngitis","Upper respiratory tract infection"]}}}